Clinical Trial Update: Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin plus radiotherapy and temozolomide to target oxidative phosphorylation in glioblastoma, IDH-wildtype; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• metformin (metformin)

Snippet

Sponsor: Hopital Foch | Conditions: Glioblastoma, IDH-wildtype | Phase 2 | Status: RECRUITING